Synopsys Inc. Amends 8-K Filing on Officer/Director Changes
Ticker: SNPS · Form: 8-K/A · Filed: Sep 18, 2025 · CIK: 883241
Sentiment: neutral
Topics: amendment, officer-changes, director-changes
TL;DR
Synopsys filed an amendment to its 8-K regarding director and officer changes.
AI Summary
Synopsys Inc. filed an amendment (No. 1) to its Form 8-K on September 18, 2025, related to events occurring on July 17, 2025. The amendment pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers.
Why It Matters
This amendment provides updated or corrected information regarding significant changes in Synopsys's board of directors and executive officer positions, which can impact corporate governance and strategic direction.
Risk Assessment
Risk Level: low — This is an amendment to a previous filing, likely for clarification or correction, and does not appear to introduce new material risks.
Key Players & Entities
- Synopsys Inc. (company) — Registrant
- July 17, 2025 (date) — Earliest event date
- September 18, 2025 (date) — Filing date
FAQ
What specific event prompted the original Form 8-K filing on July 17, 2025?
The filing indicates the original report was related to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is the purpose of this Amendment No. 1 to the Form 8-K?
The purpose of the amendment is to provide updated or corrected information regarding the events reported in the original Form 8-K filed on July 17, 2025.
What is Synopsys Inc.'s principal executive office address?
Synopsys Inc.'s principal executive offices are located at 675 Almanor Ave, Sunnyvale, California 94085.
What is the fiscal year end for Synopsys Inc.?
Synopsys Inc.'s fiscal year ends on October 31.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This Current Report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 522 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2025-09-18 16:30:33
Key Financial Figures
- $0.01 — registered Common Stock (par value of $0.01 per share) SNPS Nasdaq Global Selec
Filing Documents
- d948279d8ka.htm (8-K/A) — 24KB
- 0001193125-25-207472.txt ( ) — 136KB
- snps-20250717.xsd (EX-101.SCH) — 3KB
- snps-20250717_lab.xml (EX-101.LAB) — 18KB
- snps-20250717_pre.xml (EX-101.PRE) — 11KB
- d948279d8ka_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. SYNOPSYS, INC. Dated: September 18, 2025 By: /s/ J ANET L EE Janet Lee General Counsel and Corporate Secretary